Early Access — free while we kick the tires
EdgarHawk

Vashisht Riju

Senior Vice President

Officer
2 filings analyzed · 1 company · Latest 2026-01-13

Companies

Company Buys Sells Direction
Genpact LTD G 0 4 Net selling

Activity

January 2026
2026-01-13 Genpact LTD G
medium
Sell
16,016 shares
$747,146
Significance 5/10

Genpact SVP Vashisht Riju sold 16,016 shares at $46.65; 2 prior same-ticker sales both well-timed at 90-day horizon

Vashisht Riju sold 16,016 shares at $46.65 on 2026-01-13, reducing his holdings by 14.4% and raising $747.1K. The current price of $46.52 is -16.2% from the 52-week high of $55.54, placing the stock in the lower half of its annual range. Notably, his prior 2 trades at Genpact (both August 2025 sales) were well-timed at the 90-day mark, with subsequent declines of -4.1% and -4.0% respectively, suggesting a consistent pattern of selling before downturns. With Genpact trading at a reasonable P/E of 14.54 and reporting $1.3B quarterly revenue with 6.5% annual growth, the company's fundamentals remain solid, but the insider's historical success at identifying local peaks warrants attention.

August 2025
2025-08-25 Genpact LTD G
low
Sell
25,539 shares
$1,164,517
Significance 4/10

SVP Riju sold 25,539 shares of Genpact (G) for $1,164,516.55 in 2 transactions on 2025-08-22

Vashisht Riju, Senior Vice President at Genpact, executed 2 separate sales totaling 25,539 shares for $1,164,516.55 at a blended average price of $45.60 on August 22, 2025. The sale represents a 17.3% reduction in his post-transaction holdings to 122,270 shares. The transaction occurred near the current price of $45.45, while the stock is -18.2% from its 52-week high of $55.54 and trades at a P/E of 14.71 with steady fundamentals (6.5% annual revenue growth, $132.7M net income). The sale is material in dollar terms but reflects a disciplined reduction of a substantial remaining position, with no prior activity pattern or scheduled plan flags visible in this filing.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access